290-100 Innovation Drive
Winnipeg, MB R3T 6G2
204 453 1301
Full Time Employees:
|Mr. Marc Edwards||Pres, CEO & Director||257.48k||N/A||N/A|
|Mr. Ray Dupuis||Chief Financial Officer||162.53k||N/A||N/A|
|Mr. Kevin Cole||Pres & CEO of STEM Animal Health Inc||372.29k||N/A||N/A|
|Dr. Gregory S. Schultz Ph.D.||Chief Scientific Officer & Member of Scientific Advisory Board||N/A||N/A||1950|
|Lorne Gorber||Investor Relations||N/A||N/A||N/A|
|Ms. Lori Christofalos||VP of Quality & Compliance||N/A||N/A||N/A|
|Ms. Wendy Nachtigall||Director of Marketing||N/A||N/A||N/A|
|Nicole Sendey||Investor Relations Adviser||N/A||N/A||N/A|
|Mr. Mark Ahrens-Townsend||Advisor||N/A||N/A||N/A|
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Kane Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.